Stay updated with breaking news from Session Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Further data from study 014/015 of evenamide in treatment-resistant schizophrenia confirms potentially relevant role of glutamatergic release modification when added to TRS patients not responding... | May 3, 2023
Retail industry news, voices and jobs. Optimized for your mobile phone.
21 scientific presentations, including 7 late breakers, showcase the breadth of UCB's portfolio, reinforcing commitment to improving the lives of people living...
The abstract suggests that BBT-176 has shown its capability of inducing clinical tumor responses in EGFR triple mutation-containing patients Further exploration of the drug
Kite, a Gilead Company, presents long-term CAR T cell therapy data in lymphomas at the 48th EBMT Annual Meeting Primary analysis of pivotal data on earlier use of CAR T cell therapy as second-line treatment in relapsed/refractory diffuse large B cell lymphomaLong-term overall survival and safety management data...